Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

BACKGROUND: Evidence-based therapies used to treat coronavirus disease (COVID-19) remain limited. Azoximer bromide (AZB; Polyoxidonium(®)) is an immunomodulating molecule frequently used in the Russian Federation. It offers demonstrable therapeutic benefit in upper respiratory tract infections. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Efimov, Sergey V, Matsiyeuskaya, Natallia V, Boytsova, Olga V, Akhieva, Luydmila Yu, Kuntsevich, Elena V, Troshina, Anastasia A, Kvasova, Elena I, Tikhonov, Anton A, Khomyakova, Nadezhda F, Harrison, Francisco, Rossi, Jean-François, Hardman, Timothy C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903879/
https://www.ncbi.nlm.nih.gov/pubmed/35310299
http://dx.doi.org/10.7573/dic.2022-1-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903879/
https://www.ncbi.nlm.nih.gov/pubmed/35310299
http://dx.doi.org/10.7573/dic.2022-1-1

Ejemplares similares